每年專案
個人檔案
學歷
- 2010-2013 國立臺灣大學生醫電子與資訊學研究所博士
- 1981-1997 長庚醫學院醫學系醫學士
經歷
- 2021.08- 臺北市立萬芳醫院內科部胸腔內科主任
- 2020.02- 臺北醫學大學醫學系內科學科副教授
- 2019.08- 臺北醫學大學醫學系人工智慧醫療碩士在職專班助理教授
- 2019.05-2019.07 臺北醫學大學醫學系人工智慧醫療碩士在職專班籌備處助理教授
- 2014- 臺北市立萬芳醫院胸腔內科主治醫師
- 2014.11-2020.01 臺北醫學大學醫學系內科學科助理教授
- 2014.11-2013.12 臺北市立萬芳醫院結核病中心主任
- 2004-2013 臺北慈濟醫院主治醫師
- 2003.07-2004.10 亞東醫院主治醫師
獎項
- 2019 臺北醫學大學附屬醫院研究計畫獎
- 2014 最佳審查委員 Pharmacoepidemiology and Drug Safety.
研究興趣
- 結核病
- 慢性阻塞性肺病
- 健康資料庫
- 重症加護醫學
指紋
查看啟用 Chih-hsin Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis
Peng, T. R., Chen, J. H., Chang, Y. H., Shiang, J. C., Lee, M. C., Lee, C. H. & Wang, J. Y., 6月 2022, 於: Journal of Global Antimicrobial Resistance. 29, p. 378-385 8 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Bisphosphonate Use Is Not Associated With Tuberculosis Risk Among Patients With Osteoporosis: A Nationwide Cohort Study
Chen, J. H., Lee, C. H., Lee, M. R., Huang, P-Y., Yen, T. H., Lee, M. C., Tsai, C. W., Wang, J. Y. & Lee, J. A., 2022, (接受/付印) 於: Journal of Clinical Pharmacology.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease
Putri, D. U., Lin, C. F., Hung, C. S., Huang, C. K., Ou, T. Y., Lai, C. Y., Tseng, P. C., Cheng, C. Y. & Lee, C. H., 6月 2022, 於: Journal of Infection. 84, 6, p. e122-e125研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取 -
Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile
Putri, D. U., Chen, C. L., Wang, C. H., Sue, Y. M., Tseng, P. C., Lin, C. F., Tsai, C. W., Liu, Y. J. & Lee, C. H., 4月 2022, 於: Journal of Microbiology, Immunology and Infection. 55, 2, p. 332-335 4 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Isoniazid level and flu-like symptoms during rifapentine-based tuberculosis preventive therapy: A population pharmacokinetic analysis
Lee, M. C., Fujita, Y., Muraki, S., Huang, H. L., Lee, C. H., Wang, J. Y. & Ieiri, I., 2022, (接受/付印) 於: British Journal of Clinical Pharmacology. 89, 2, p. 714-726 13 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Additional file 2: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119147.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119147/1
資料集: Dataset
-
Additional file 6: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119222.v1, https://springernature.figshare.com/articles/Additional_file_6_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119222/1
資料集: Dataset
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Creator), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4063952.v1, https://figshare.com/collections/Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/4063952/1
資料集: Dataset
-
Additional file 3: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119174.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119174/1
資料集: Dataset
-
Additional file 5: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119204.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119204/1
資料集: Dataset